1. Video Library
  2. Rob Skillicorn, CDX Medical Technologies - Compact Portable Extracorporeal Bypass Pump | LSI USA '25

Rob Skillicorn, CDX Medical Technologies - Compact Portable Extracorporeal Bypass Pump | LSI USA '25

CDX Medical Technologies specializes in advanced diagnostic solutions, focusing on the early detection and prevention of diseases through innovative tissue biopsy and laboratory services.
Speakers
Rob Skillicorn
CDX Medical Technologies
Bio Bio
View Video Transcript

Rob Skillicorn  0:04  
So I want to talk about CDX Medical Technologies, and what we have have done. And I will This is really about revolutionize, right? We're going to talk about the way that the market currently is in this in this segment, and we need to talk about changes, right? We've all heard through different speeches that we're here to revolutionize and change. You know what we're currently doing in the market and how we can help patient safety and and care. So with that, let's continue. So a little background. CDX focuses on ECMO for respiratory failure market. We've developed a revolutionized C respiratory ECMO, vv ECMO device. I will tell you all the design work is completed, and I'm jumping a little bit ahead, but we anticipate to have this in the market field in June, or, excuse me, in October of 2025 it's a value strategy. It's a modest capital that we need to in order to bring this to the marketplace for full potential. So I want to go back in time just a little bit and tell me if this looks familiar, right? This is currently, you know, what we're currently dealing with, from a technology standpoint, there hasn't been a lot of change in the marketplace for the last couple decades. You've got a 60 pound device. It is static. It, you know, the patient, it's, it's, it's, you know, they can't it's not mobile. You got six feet of tubing. And there's a lot of complications with this, with the way that is out there currently in the marketplace. So with that, I'm going to show you. I brought my fanny pack today. This is, this is the device. It's that big. That's it. This is actually the pump. This is the unit. It weighs a total of six pounds. This is what we've we've created. This is the iPhone of this industry. I want to really quickly there the gentleman that has created this. He's out on down here in the front. His name's Gopal, but he he can give you a ton more on this, on this area that I am, my backgrounds in regulatory compliance and quality assurance, as we were just talking about so but again, back to the conversation. We've eliminated the challenges that that you know you talk to doctors and clinicians and you know, of the challenges that they run with these type of devices. And I was actually just talking to one right before we started. And you can see all of the areas that that you see highlighted in in, you know, black, we've eliminated small cannular circuits. There's no heat emission that comes off of this device. These devices get super, super hot, to the point that they can burn somebody, you know, post use of staffing demands. It reduces the overall, you know, staffing needs in order to, you know, to utilize or set one of these machines up and to maintain it. You know, I joke the other day, and I said my eight year old, you know, son could actually do that. So, you know, it's very, very simple to use. And again, as I mentioned just a minute, we have a pathway to for full 510, K clearance, the other, the other benefit to this as well. Just to share with you, we have supporting partners, you know, companies like Vanderbilt, Cleveland Clinic, you know, those type of that are supporting the pathway and helping us as we, as we proceed forward through this through this journey. Again, just a little bit about the design. It's fully carbonated design. It has a new impeller geometry for broad spectrum indications. We have designed it to be very efficient from a manufacturing process and from a regulatory and quality standpoint. Novel design, single piece, electromagnetic pairing standard and the whole device that I was just showing you, as it comes from the packaging standpoint, can be disposed. So this is what this is, all you this is what gets tossed away. Back on the data. From a performance standpoint, we have tested this. Whether the competitors currently in the market. It'll be the next slide, and we are able to produce over eight liters with 250 milliliters of mercury. Here's our current patents on the technology that we currently have. I. And there's the competitive landscape currently, and you can see that every area that we've compared against the competitors either meets or exceeds the current, the current technology out there. The different, biggest difference is that they're all, they're all, you know, they're non actual Axios. So this is the first Axios device that will be in the marketplace. Regulatory. That's my world, as we were just talking so the the that's the pathway you can see the product release, and the clinician, the clinics that I have said as soon as we get approval, that they're ready to support our pathway. And in summary, again, fundamentally, the vv ECMO, it's a strong market. It's innovation from an ECMO space. It's is lagging. There has, again, there has not been a lot of changes for the last couple decades, and in its it reduces the risk overall, and it's the paper bubble with all of the the clinicians and the hospitals and the support that we have that is to help you support us. And with that, we're looking to raise two, two and a half million to finish our pathway into commercialization, and I want to thank you all for your your time today. 


 

LSI Europe ‘25 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

September 7th - 11th, 202 JW Marriott Grosvenor House London Register arrow
lsi logo

Events

Explore Media

Market Intelligence

Resources

Market Intelligence

Schedule an exploratory call

Request Info

17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647

714-847-3540

© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy